JP2008540513A - スキンケアのための組成物及び方法 - Google Patents

スキンケアのための組成物及び方法 Download PDF

Info

Publication number
JP2008540513A
JP2008540513A JP2008510723A JP2008510723A JP2008540513A JP 2008540513 A JP2008540513 A JP 2008540513A JP 2008510723 A JP2008510723 A JP 2008510723A JP 2008510723 A JP2008510723 A JP 2008510723A JP 2008540513 A JP2008540513 A JP 2008540513A
Authority
JP
Japan
Prior art keywords
vitamin
nicotinamide
skin
cadpr
aging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008510723A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540513A5 (OSRAM
Inventor
ハレル、アビカム
− チェン、ジーブ イベン
Original Assignee
ダーミプソル リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ダーミプソル リミテッド filed Critical ダーミプソル リミテッド
Publication of JP2008540513A publication Critical patent/JP2008540513A/ja
Publication of JP2008540513A5 publication Critical patent/JP2008540513A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
JP2008510723A 2005-05-10 2006-05-10 スキンケアのための組成物及び方法 Pending JP2008540513A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67932905P 2005-05-10 2005-05-10
PCT/IL2006/000552 WO2006120681A2 (en) 2005-05-10 2006-05-10 Compositions and methods for skin care

Publications (2)

Publication Number Publication Date
JP2008540513A true JP2008540513A (ja) 2008-11-20
JP2008540513A5 JP2008540513A5 (OSRAM) 2009-06-18

Family

ID=37396969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008510723A Pending JP2008540513A (ja) 2005-05-10 2006-05-10 スキンケアのための組成物及び方法

Country Status (7)

Country Link
US (1) US8034788B2 (OSRAM)
EP (1) EP1879449A4 (OSRAM)
JP (1) JP2008540513A (OSRAM)
CN (1) CN101217868A (OSRAM)
AU (1) AU2006245282A1 (OSRAM)
CA (1) CA2608021A1 (OSRAM)
WO (1) WO2006120681A2 (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
AU2006245283B2 (en) * 2005-05-10 2012-11-01 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
WO2008131256A1 (en) * 2007-04-19 2008-10-30 Trinity Laboratories Inc. Improved treatments for premature ejaculation in humans
WO2009022338A2 (en) * 2007-08-16 2009-02-19 Saher Hamed Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
FR2925313A1 (fr) * 2007-12-19 2009-06-26 Oreal Utilisation cosmetique de proteines de type plakoglobine
FR2925314B1 (fr) * 2007-12-19 2012-11-23 Oreal Utilisation cosmetique de proteines de type transglutaminase 3
FR2936421B1 (fr) * 2008-09-29 2011-02-11 Bouill Mariya Le Produit de beaute et de soin pour faire disparaitre les rides du visage, empecher leur apparition et maintenir la tonicite de la peau
RU2397770C1 (ru) * 2008-12-30 2010-08-27 Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды" Поливитаминная мазь для смягчения, питания и заживления кожи и способ ее получения
EP2464357B1 (en) 2009-08-14 2019-05-22 Berg LLC Vitamin d3 and analogs thereof for treating alopecia
US20120322776A1 (en) * 2009-12-22 2012-12-20 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
WO2011087525A1 (en) * 2010-01-17 2011-07-21 The Procter & Gamble Company Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
CN108430449B (zh) * 2016-01-11 2023-01-24 宝洁公司 处理皮肤状况的方法以及用于其的组合物
US20200100997A1 (en) * 2017-02-06 2020-04-02 3Skin As Sunscreen Composition
KR102069088B1 (ko) * 2018-04-02 2020-01-22 양미경 탈모의 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학 또는 화장료 조성물
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
BR112021023035A2 (pt) * 2019-05-17 2022-01-25 Univ Pennsylvania Métodos e composições para tratar obesidade e/ou transtornos cutâneos
JP7590462B2 (ja) 2020-06-01 2024-11-26 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
CN118384058A (zh) * 2024-04-08 2024-07-26 云南贝泰妮生物科技集团股份有限公司 烟酰胺在制备预防和/或治疗皮肤光老化护肤品和药物中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001051051A2 (en) * 2000-01-11 2001-07-19 Avikam Harel AGENTS, SUCH AS NICOTINAMIDE OR cADPR FOR THE TREATMENT OF SKIN DISORDERS
JP2002527356A (ja) * 1998-07-16 2002-08-27 ジェントリックス・リミテッド・ライアビリティ・カンパニー 異常細胞増殖処置のための組成物および方法
WO2004006887A2 (en) * 2002-07-11 2004-01-22 Dermipsor Ltd. Composition and methods for the treatment of skin disorders

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120722A (en) 1984-02-08 1992-06-09 Hoffmann-La Roche Inc. Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia
DE3666587D1 (en) 1985-08-02 1989-11-30 Leo Pharm Prod Ltd Novel vitamin d analogues
US4804502A (en) 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5145846A (en) 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4851401A (en) 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
CA1333616C (en) 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
GB9007236D0 (en) 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
ES2093180T3 (es) 1991-07-05 1996-12-16 Duphar Int Res Compuesto de vitamina d, metodo de preparar este compuesto y producto intermedio de dicho metodo.
DE4141746A1 (de) 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
US5237629A (en) * 1992-03-19 1993-08-17 The United States Of America As Represented By The United States Department Of Energy Digitally controlled distributed phase shifter
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
US5747479A (en) 1996-01-03 1998-05-05 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
DE69704272D1 (de) 1996-05-02 2001-04-19 Duphar Int Res Vitamin d analoga und verfahren zu ihrer herstellung
US5811414A (en) 1997-05-16 1998-09-22 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
US6262041B1 (en) 1998-04-06 2001-07-17 Bertek Pharmaceuticals, Inc. Use of vitamin D analogs to treat conditions related to increased oxidative stress
US6552009B2 (en) 1998-07-16 2003-04-22 Gentrix Llc Compositions and methods of treating abnormal cell proliferation
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
ES2388425T5 (es) 1999-04-23 2020-02-12 Leo Pharma As Composición farmacéutica no acuosa para uso dérmico para tratar la psoriasis que comprende una vitamina D, un corticoesteroide y un componente disolvente
FR2801305B1 (fr) 1999-11-24 2002-12-06 Galderma Res & Dev Analogues de la vitamine d

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002527356A (ja) * 1998-07-16 2002-08-27 ジェントリックス・リミテッド・ライアビリティ・カンパニー 異常細胞増殖処置のための組成物および方法
WO2001051051A2 (en) * 2000-01-11 2001-07-19 Avikam Harel AGENTS, SUCH AS NICOTINAMIDE OR cADPR FOR THE TREATMENT OF SKIN DISORDERS
WO2004006887A2 (en) * 2002-07-11 2004-01-22 Dermipsor Ltd. Composition and methods for the treatment of skin disorders

Also Published As

Publication number Publication date
AU2006245282A1 (en) 2006-11-16
EP1879449A4 (en) 2009-12-16
WO2006120681A3 (en) 2007-01-25
CN101217868A (zh) 2008-07-09
WO2006120681A2 (en) 2006-11-16
EP1879449A2 (en) 2008-01-23
US8034788B2 (en) 2011-10-11
CA2608021A1 (en) 2006-11-16
US20080312181A1 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
US8034788B2 (en) Composition and methods for skin care
JP3802034B2 (ja) ベツリン酸を含む化粧品組成物
US5621008A (en) N-acyl-ethylene-triacetic acids
RU2562140C2 (ru) Композиция и способ для лечения признаков старения кожи
US20160175223A1 (en) Anti-aging compositions comprising bile acid-fatty acid conjugates
JP2008540514A (ja) 過剰増殖表皮疾患の治療用組成物及び方法
KR20150143698A (ko) 항산화제 조성물 및 이의 사용 방법
EP3030229B1 (en) Anti-acne compositions comprising bile acid-fatty acid conjugates
EP1565189A1 (en) Anti-aging skin care composition and uses thereof
EP1000613A2 (en) Composition against the ageing and its use
AU658461B2 (en) Skin care composition
JP2005507882A (ja) 皮膚不調の治療方法
JP3792651B2 (ja) 二重区画包装においてレチノイド、レチノイドブースター、およびフィトエストロゲンを含んでいるスキンケア製品
DE60124307T2 (de) Hautpflegemittel enthaltend retinoide und phytoöstrogene in einem doppelkammer-behältnis
US20050197407A1 (en) Method and preparation for reducing irritation and/or inflammatory reaction in human skin
US20140037561A1 (en) Composition and methods of enhanced skin cell turnover
US20060148907A1 (en) Topical antinflammatory preparations of y-terpinene
JP2007284430A (ja) グルタチオン産生促進剤
ES2356939T3 (es) Composiciones que contienen retinoide y derivados de cromenona.
IL187237A (en) Preparations containing calcipotriol and nicotinamide for use in skin care
US20240423897A1 (en) Longevity serum
JPH11246389A (ja) 美白用化粧組成物
HK1003028B (en) Skin care composition

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090427

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090427

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120207

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120420

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120427

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20121005